Fig. 1 · Structure
Documents & Downloads
Ethybenztropine hydrochloride
Muscarinic Receptor Blocker
Ethybenztropine hydrochloride is a potent muscarinic receptor blocker with established anticholinergic properties. This compound demonstrates significant antiparkinsonian activity, effectively improving motor symptoms in patients with Parkinson's disease. Additionally, Ethybenztropine hydrochloride may exhibit dopamine reuptake inhibitory effects, contributing to its therapeutic efficacy. It is utilized in research applications focused on neuropharmacology and the modulation of neurotransmitter balance.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Antagonist |
| CAS Number | 26598-44-7 |
| Applications | Muscarinic Receptor Blocker |
| Formula | C22H28ClNO |
| Molecular Weight | 357.92 |
| Synonyms | Ponalid hydrochloride; UK 738 hydrochloride |
| SMILES | CCN([C@](CC1)([H])C2)[C@@]1([H])C[C@@H]2OC(C3=CC=CC=C3)C4=CC=CC=C4.Cl |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.